I doubt Merck is running on Bergertime. Ever since Harvey made the orginal deal with Merck I have been thinking it was great because it increased the odds it wouldn't get screwed up and money for additional trials would not be a concern.
Merck will submit when they are good and ready. Perhaps the "delay" is to get additional data to buttress their submission.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.